InspireMD has received approval for its investigational device exemption (IDE) application from the US Food and Drug Administration (FDA) to initiate MASTER II clinical study of its MGuard embolic protection stent (EPS). The CE-marked ...
Tags: InspireMD, Protection Stent Study
InspireMD's Mguard embolic protection stent has demonstrated a positive outcome in treating patients suffering heart attacks when compared to bare metal or drug-eluting stents during the study. The multi-center randomized MASTER ...
Tags: embolic protection stent, clinical trial, clinical technology